DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Emcure Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·6 Aug 2026, 4:29 pm

Emcure Pharmaceuticals L

Emcure Pharmaceuticals has informed exchanges that it is holding a meeting with analysts and institutional investors. This update confirms the company is engaging with the investment community to discuss its business strategy and future outlook.

For investors, this meeting provides an opportunity to gain clarity on the company's operational roadmap. It is a key indicator that management is focused on transparency and is actively communicating with the market to address investor concerns.

Investors should watch for any specific guidance or commentary regarding the company's growth trajectory, product pipeline, or market performance during the discussion. The market will likely react to any insights shared by the management regarding the current business environment.